Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions

Chemistry and Biology

Volumn 16, Issue 8, 2009, Pages 803-814

  Shriver, Zachary ^a   Raman, Rahul ^a   Viswanathan, Karthik ^a   Sasisekharan, Ram ^a  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

CHEMBIO; MIRCOBIO

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; POLYSACCHARIDE; VIRUS RECEPTOR;

CONFORMATION; HUMAN; INFLUENZA VIRUS A; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION; REVIEW;

CARBOHYDRATE CONFORMATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, VIRUS;

BACTERIA (MICROORGANISMS); INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 69049101988     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.08.002     Document Type: Review

References (98)

1. Alexopoulou A.N., Multhaupt H.A., and Couchman J.R. Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 39 (2007) 505-528
2. Belser J.A., Blixt O., Chen L.M., Pappas C., Maines T.R., Van Hoeven N., Donis R., Busch J., McBride R., Paulson J.C., et al. Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc. Natl. Acad. Sci. USA 105 (2008) 7558-7563
3. Bewley C.A. Illuminating the switch in influenza viruses. Nat. Biotechnol. 26 (2008) 60-62
4. Bhatia P.K., and Mukhopadhyay A. Protein glycosylation: implications for in vivo functions and therapeutic applications. Adv. Biochem. Eng. Biotechnol. 64 (1999) 155-201
5. Blixt O., and Razi N. Chemoenzymatic synthesis of glycan libraries. Methods Enzymol. 415 (2006) 137-153
6. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., Bryan M.C., Fazio F., Calarese D., Stevens J., et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101 (2004) 17033-17038
7. Bovin N.V., Tuzikov A.B., Chinarev A.A., and Gambaryan A.S. Multimeric glycotherapeutics: new paradigm. Glycoconj. J. 21 (2004) 471-478
8. Carroll S.M., Higa H.H., and Paulson J.C. Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J. Biol. Chem. 256 (1981) 8357-8363
9. Case D.A., Cheatham III T.E., Darden T., Gohlke H., Luo R., Merz Jr. K.M., Onufriev A., Simmerling C., Wang B., and Woods R.J. The Amber biomolecular simulation programs. J. Comput. Chem. 26 (2005) 1668-1688
10. Chandrasekaran A., Srinivasan A., Raman R., Viswanathan K., Raguram S., Tumpey T.M., Sasisekharan V., and Sasisekharan R. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26 (2008) 107-113
11. Collins B.E., and Paulson J.C. Cell surface biology mediated by low affinity multivalent protein-glycan interactions. Curr. Opin. Chem. Biol. 8 (2004) 617-625
12. Comelli E.M., Sutton-Smith M., Yan Q., Amado M., Panico M., Gilmartin T., Whisenant T., Lanigan C.M., Head S.R., Goldberg D., et al. Activation of murine CD4+ and CD8+ T lymphocytes leads to dramatic remodeling of N-linked glycans. J. Immunol. 177 (2006) 2431-2440
13. Connor R.J., Kawaoka Y., Webster R.G., and Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205 (1994) 17-23
14. Crocker P.R. Siglecs in innate immunity. Curr. Opin. Pharmacol. 5 (2005) 431-437
15. Crocker P.R., Paulson J.C., and Varki A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7 (2007) 255-266
16. Dam T.K., and Brewer C.F. Effects of clustered epitopes in multivalent ligand-receptor interactions. Biochemistry 47 (2008) 8470-8476
17. Dam T.K., Gerken T.A., and Brewer C.F. Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: importance of entropy in the bind and jump mechanism. Biochemistry 48 (2009) 3822-3827
18. Duverger E., Frison N., Roche A.C., and Monsigny M. Carbohydrate-lectin interactions assessed by surface plasmon resonance. Biochimie 85 (2003) 167-179
19. Eisen M.B., Sabesan S., Skehel J.J., and Wiley D.C. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology 232 (1997) 19-31
20. Feizi T., Fazio F., Chai W., and Wong C.H. Carbohydrate microarrays - a new set of technologies at the frontiers of glycomics. Curr. Opin. Struct. Biol. 13 (2003) 637-645
21. Fukui S., Feizi T., Galustian C., Lawson A.M., and Chai W. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat. Biotechnol. 20 (2002) 1011-1017
22. Gambaryan A.S., and Matrosovich M.N. A solid-phase enzyme-linked assay for influenza virus receptor-binding activity. J. Virol. Methods 39 (1992) 111-123
23. Gambaryan A.S., Piskarev V.E., Yamskov I.A., Sakharov A.M., Tuzikov A.B., Bovin N.V., Nifant'ev N.E., and Matrosovich M.N. Human influenza virus recognition of sialyloligosaccharides. FEBS Lett. 366 (1995) 57-60
24. Gambaryan A., Yamnikova S., Lvov D., Tuzikov A., Chinarev A., Pazynina G., Webster R., Matrosovich M., and Bovin N. Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology 334 (2005) 276-283
25. Gambaryan A., Tuzikov A., Pazynina G., Bovin N., Balish A., and Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 344 (2006) 432-438
26. Gambaryan A.S., Tuzikov A.B., Pazynina G.V., Desheva J.A., Bovin N.V., Matrosovich M.N., and Klimov A.I. 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol. J. 5 (2008) 85
27. Gamblin S.J., Haire L.F., Russell R.J., Stevens D.J., Xiao B., Ha Y., Vasisht N., Steinhauer D.A., Daniels R.S., Elliot A., et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303 (2004) 1838-1842
28. Gildersleeve J.C., Oyelaran O., Simpson J.T., and Allred B. Improved procedure for direct coupling of carbohydrates to proteins via reductive amination. Bioconjug. Chem. 19 (2008) 1485-1490
29. Glaser L., Zamarin D., Acland H.M., Spackman E., Palese P., Garcia-Sastre A., and Tewari D. Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America. Glycoconj. J. 23 (2006) 93-99
30. Grun C.H., van Vliet S.J., Schiphorst W.E., Bank C.M., Meyer S., van Die I., and van Kooyk Y. One-step biotinylation procedure for carbohydrates to study carbohydrate-protein interactions. Anal. Biochem. 354 (2006) 54-63
31. Ha Y., Stevens D.J., Skehel J.J., and Wiley D.C. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA 98 (2001) 11181-11186
32. Ha Y., Stevens D.J., Skehel J.J., and Wiley D.C. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology 309 (2003) 209-218
33. Hanson S., Best M., Bryan M.C., and Wong C.H. Chemoenzymatic synthesis of oligosaccharides and glycoproteins. Trends Biochem. Sci. 29 (2004) 656-663
34. Hatakeyama S., Sakai-Tagawa Y., Kiso M., Goto H., Kawakami C., Mitamura K., Sugaya N., Suzuki Y., and Kawaoka Y. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J. Clin. Microbiol. 43 (2005) 4139-4146
35. Helenius A., and Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73 (2004) 1019-1049
36. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97 (2000) 6108-6113
37. Houseman B.T., and Mrksich M. Carbohydrate arrays for the evaluation of protein binding and enzymatic modification. Chem. Biol. 9 (2002) 443-454
38. Huang W., Ochiai H., Zhang X., and Wang L.X. Introducing N-glycans into natural products through a chemoenzymatic approach. Carbohydr. Res. 343 (2008) 2903-2913
39. Ibricevic A., Pekosz A., Walter M.J., Newby C., Battaile J.T., Brown E.G., Holtzman M.J., and Brody S.L. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80 (2006) 7469-7480
40. Karamanska R., Clarke J., Blixt O., Macrae J.I., Zhang J.Q., Crocker P.R., Laurent N., Wright A., Flitsch S.L., Russell D.A., et al. Surface plasmon resonance imaging for real-time, label-free analysis of protein interactions with carbohydrate microarrays. Glycoconj. J. 25 (2008) 69-74
41. Kawashima H., Petryniak B., Hiraoka N., Mitoma J., Huckaby V., Nakayama J., Uchimura K., Kadomatsu K., Muramatsu T., Lowe J.B., et al. N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat. Immunol. 6 (2005) 1096-1104
42. Kiessling L.L., Gestwicki J.E., and Strong L.E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr. Opin. Chem. Biol. 4 (2000) 696-703
43. Kirschner K.N., Yongye A.B., Tschampel S.M., Gonzalez-Outeirino J., Daniels C.R., Foley B.L., and Woods R.J. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29 (2008) 622-655
44. Kumari K., Gulati S., Smith D.F., Gulati U., Cummings R.D., and Air G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 4 (2007) 42
45. Liang P.H., Wu C.Y., Greenberg W.A., and Wong C.H. Glycan arrays: biological and medical applications. Curr. Opin. Chem. Biol. 12 (2008) 86-92
46. Lowe J.B. Glycosyltransferases and glycan structures contributing to the adhesive activities of L-, E- and P-selectin counter-receptors. Biochem. Soc. Symp. 69 (2002) 33-45
47. Lowen A.C., and Palese P. Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect. Disord. Drug Targets 7 (2007) 318-328
48. Luytjes W., Krystal M., Enami M., Parvin J.D., and Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59 (1989) 1107-1113
49. Maines T.R., Chen L.M., Matsuoka Y., Chen H., Rowe T., Ortin J., Falcon A., Nguyen T.H., Maile Q., Sedyaningsih E.R., et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. USA 103 (2006) 12121-12126
50. Maines T.R., Jayaraman A., Belser J.A., Wadford D.A., Pappas C., Zeng H., Gustin K.M., Pearce M.B., Viswanathan K., Shriver Z.H., et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 (2009) 484-487
51. Mammen M., Dahmann G., and Whitesides G.M. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. J. Med. Chem. 38 (1995) 4179-4190
52. Mammen M., Choi S.K., and Whitesides G.M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37 (1998) 2755-2794
53. Manzi A.E., Norgard-Sumnicht K., Argade S., Marth J.D., van Halbeek H., and Varki A. Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures. Glycobiology 10 (2000) 669-689
54. Matrosovich M., Tuzikov A., Bovin N., Gambaryan A., Klimov A., Castrucci M.R., Donatelli I., and Kawaoka Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74 (2000) 8502-8512
55. Matrosovich M., Matrosovich T., Uhlendorff J., Garten W., and Klenk H.D. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 361 (2007) 384-390
56. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., and Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101 (2004) 4620-4624
57. Mercey E., Sadir R., Maillart E., Roget A., Baleux F., Lortat-Jacob H., and Livache T. Polypyrrole oligosaccharide array and surface plasmon resonance imaging for the measurement of glycosaminoglycan binding interactions. Anal. Chem. 80 (2008) 3476-3482
58. Norgard-Sumnicht K., Bai X., Esko J.D., Varki A., and Manzi A.E. Exploring the outcome of genetic modifications of glycosylation in cultured cell lines by concurrent isolation of the major classes of vertebrate glycans. Glycobiology 10 (2000) 691-700
59. Oyelaran O., and Gildersleeve J.C. Application of carbohydrate array technology to antigen discovery and vaccine development. Expert Rev. Vaccines 6 (2007) 957-969
60. Palese P. Influenza: old and new threats. Nat. Med. 10 (2004) S82-S87
61. Pappas C., Aguilar P.V., Basler C.F., Solorzano A., Zeng H., Perrone L.A., Palese P., Garcia-Sastre A., Katz J.M., and Tumpey T.M. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. USA 105 (2008) 3064-3069
62. Paulson J.C., and Rogers G.N. Resialylated erythrocytes for assessment of the specificity of sialyloligosaccharide binding proteins. Methods Enzymol. 138 (1987) 162-168
63. Pleschka S., Jaskunas R., Engelhardt O.G., Zurcher T., Palese P., and Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70 (1996) 4188-4192
64. Rogers G.N., and Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127 (1983) 361-373
65. Rogers G.N., Paulson J.C., Daniels R.S., Skehel J.J., Wilson I.A., and Wiley D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304 (1983) 76-78
66. Rudd P.M., Wormald M.R., and Dwek R.A. Sugar-mediated ligand-receptor interactions in the immune system. Trends Biotechnol. 22 (2004) 524-530
67. Russell R.J., Stevens D.J., Haire L.F., Gamblin S.J., and Skehel J.J. Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj. J. 23 (2006) 85-92
68. Sauter N.K., Hanson J.E., Glick G.D., Brown J.H., Crowther R.L., Park S.J., Skehel J.J., and Wiley D.C. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 31 (1992) 9609-9621
69. Seeberger P.H., and Werz D.B. Synthesis and medical applications of oligosaccharides. Nature 446 (2007) 1046-1051
70. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., and Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006) 435-436
71. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
72. Smithson G., Rogers C.E., Smith P.L., Scheidegger E.P., Petryniak B., Myers J.T., Kim D.S., Homeister J.W., and Lowe J.B. Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes. J. Exp. Med. 194 (2001) 601-614
73. Song X., Xia B., Stowell S.R., Lasanajak Y., Smith D.F., and Cummings R.D. Novel fluorescent glycan microarray strategy reveals ligands for galectins. Chem. Biol. 16 (2009) 36-47
74. Soundararajan V., Tharakaraman K., Raman R., Raguram S., Shriver Z., Sasisekharan V., and Sasisekharan R. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol. 27 (2009) 510-513
75. Srinivasan A., Viswanathan K., Raman R., Chandrasekaran A., Raguram S., Tumpey T.M., Sasisekharan V., and Sasisekharan R. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl. Acad. Sci. USA 105 (2008) 2800-2805
76. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., and Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355 (2006) 1143-1155
77. Stevens J., Blixt O., Paulson J.C., and Wilson I.A. Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat. Rev. Microbiol. 4 (2006) 857-864
78. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., and Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006) 404-410
79. Stevens J., Blixt O., Chen L.M., Donis R.O., Paulson J.C., and Wilson I.A. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J. Mol. Biol. 381 (2008) 1382-1394
80. Stray S.J., Cummings R.D., and Air G.M. Influenza virus infection of desialylated cells. Glycobiology 10 (2000) 649-658
81. Taylor M.E., and Drickamer K. Paradigms for glycan-binding receptors in cell adhesion. Curr. Opin. Cell Biol. 19 (2007) 572-577
82. Totani K., Kubota T., Kuroda T., Murata T., Hidari K.I., Suzuki T., Suzuki Y., Kobayashi K., Ashida H., Yamamoto K., et al. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13 (2003) 315-326
83. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., Cox N.J., Katz J.M., Taubenberger J.K., Palese P., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 (2005) 77-80
84. Tumpey T.M., Maines T.R., Van Hoeven N., Glaser L., Solorzano A., Pappas C., Cox N.J., Swayne D.E., Palese P., Katz J.M., et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 (2007) 655-659
85. Uematsu R., Furukawa J., Nakagawa H., Shinohara Y., Deguchi K., Monde K., and Nishimura S. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis. Mol. Cell. Proteomics 4 (2005) 1977-1989
86. van der Laan J.W., Herberts C., Lambkin-Williams R., Boyers A., Mann A.J., and Oxford J. Animal models in influenza vaccine testing. Expert Rev. Vaccines 7 (2008) 783-793
87. van Die I., and Cummings R.D. Glycans modulate immune responses in helminth infections and allergy. Chem. Immunol. Allergy 90 (2006) 91-112
88. van Hoeven N., Pappas C., Belser J.A., Maines T.R., Zeng H., Garcia-Sastre A., Sasisekharan R., Katz J.M., and Tumpey T.M. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. USA. 106 (2009) 3366-3371
89. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., and Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J Pathol. 171 (2007) 1215-1223
90. Varki A., Cummings R.D., Esko J.D., Freeze H.H., Hart G.W., and Etzler M.E. Essentials of Glycobiology (2008), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
91. Wan H., Sorrell E.M., Song H., Hossain M.J., Ramirez-Nieto G., Monne I., Stevens J., Cattoli G., Capua I., Chen L.M., et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 3 (2008) e2923
92. Wang L., Fuster M., Sriramarao P., and Esko J.D. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat. Immunol. 6 (2005) 902-910
93. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., and Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333 (1988) 426-431
94. Woods R.J. Computational carbohydrate chemistry: what theoretical methods can tell us. Glycoconj. J. 15 (1998) 209-216
95. Xia B., Kawar Z.S., Ju T., Alvarez R.A., Sachdev G.P., and Cummings R.D. Versatile fluorescent derivatization of glycans for glycomic analysis. Nat. Methods 2 (2005) 845-850
96. Xu D., Newhouse E.I., Amaro R.E., Pao H.C., Cheng L.S., Markwick P.R., McCammon J.A., Li W.W., and Arzberger P.W. Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective. J. Mol. Biol. 387 (2009) 465-491
97. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., Muramoto Y., Ito M., Kiso M., Horimoto T., et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444 (2006) 378-382
98. Yang Z.Y., Wei C.J., Kong W.P., Wu L., Xu L., Smith D.F., and Nabel G.J. Immunization by avian h5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317 (2007) 825-828